Warning: The NCBI web site requires JavaScript to function. more...
Monitoring of gene knockouts: genome-wide profiling of conditionally essential genes.
Smith LK, Gomez MJ, Shatalin KY, Lee H, Neyfakh AA.
Genome Biol. 2007;8(5):R87.
Related citations
Novel genetic techniques and approaches in the microbial genomics era: identification and/or validation of targets for the discovery of new antibacterial agents.
Pucci MJ.
Drugs R D. 2007;8(4):201-12. Review.
Bacterial targets and antibiotics: genome-based drug discovery.
Gray CP, Keck W.
Cell Mol Life Sci. 1999 Nov 30;56(9-10):779-87. Review.
Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach.
Chalker AF, Lunsford RD.
Pharmacol Ther. 2002 Jul;95(1):1-20. Review.
Functional genomics in antibacterial drug discovery.
Freiberg C, Brötz-Oesterhelt H.
Drug Discov Today. 2005 Jul 1;10(13):927-35. Review.
Streptococcus pneumoniae as a genomics platform for broad-spectrum antibiotic discovery.
Glass JI, Belanger AE, Robertson GT.
Curr Opin Microbiol. 2002 Jun;5(3):338-42. Review.
Genome-wide screening of genes affecting glycogen metabolism in Escherichia coli K-12.
Eydallin G, Viale AM, Morán-Zorzano MT, Muñoz FJ, Montero M, Baroja-Fernández E, Pozueta-Romero J.
FEBS Lett. 2007 Jun 26;581(16):2947-53. Epub 2007 May 25.
How essential are nonessential genes?
Fang G, Rocha E, Danchin A.
Mol Biol Evol. 2005 Nov;22(11):2147-56. Epub 2005 Jul 13.
Use of genomics to select antibacterial targets.
Biochem Pharmacol. 2006 Mar 30;71(7):1066-72. Epub 2006 Jan 18. Review.
The role of genomics in the discovery of novel targets for antibiotic therapy.
Ji Y.
Pharmacogenomics. 2002 May;3(3):315-23. Review.
Black holes, antivirulence genes, and gene inactivation in the evolution of bacterial pathogens.
Maurelli AT.
FEMS Microbiol Lett. 2007 Feb;267(1):1-8. Review.
Transposon-based approaches to identify essential bacterial genes.
Judson N, Mekalanos JJ.
Trends Microbiol. 2000 Nov;8(11):521-6. Review.
Transposon-based strategies for the identification of essential bacterial genes.
Reznikoff WS, Winterberg KM.
Methods Mol Biol. 2008;416:13-26. Review.
Novel targets for the future development of antibacterial agents.
McDevitt D, Payne DJ, Holmes DJ, Rosenberg M.
Symp Ser Soc Appl Microbiol. 2002;(31):28S-34S. Review.
Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting.
Cantón R.
Clin Microbiol Infect. 2009 Jan;15 Suppl 1:20-5. Review.
Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of wastewater treatment plant bacteria showing reduced susceptibility to selected antibiotics.
Szczepanowski R, Linke B, Krahn I, Gartemann KH, Gützkow T, Eichler W, Pühler A, Schlüter A.
Microbiology. 2009 Jul;155(Pt 7):2306-19. Epub 2009 Apr 23.
High-throughput, kingdom-wide prediction and annotation of bacterial non-coding RNAs.
Livny J, Teonadi H, Livny M, Waldor MK.
PLoS One. 2008 Sep 12;3(9):e3197. Erratum in: PLoS ONE. 2008;3(11). doi: 10.1371/annotation/a03e1870-1dd7-4c16-8c46-2268eeb2a50a.
The impact of transcriptome and proteome analyses on antibiotic drug discovery.
Freiberg C, Brötz-Oesterhelt H, Labischinski H.
Curr Opin Microbiol. 2004 Oct;7(5):451-9. Review.
Antibiotics and the post-genome revolution.
Amini S, Tavazoie S.
Curr Opin Microbiol. 2011 Oct;14(5):513-8. Epub 2011 Aug 3. Review.
Microbial fitness and genome dynamics.
Tønjum T, Seeberg E.
Trends Microbiol. 2001 Aug;9(8):356-8. Review. No abstract available.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on